Tempest Therapeutics, Inc. Common Stock (TPST) is a publicly traded Healthcare sector company. As of July 15, 2026, TPST trades at $0.99 with a market cap of $15.72M and a P/E ratio of -0.15. TPST moved +0.00% today. Year to date, TPST is -31.67%; over the trailing twelve months it is -71.58%. Its 52-week range spans $0.94 to $6.83. Rallies surfaces TPST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TPST shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.99 |
| Market Cap | $15.72M |
| P/E Ratio | -0.15 |
| EPS | $-6.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.83 |
| 52-Week Low | $0.94 |
| Volume | 34.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.26M |
| Gross Margin | 0.00% |
TPST analyst coverage data. Average price target: $0.00.